ストックスクリーナーアプリを入手
42.83
0.58%
-0.25
アフターアワーズ：
42.82
-0.010
-0.02%
前日終値:
$43.08
開ける：
$42.91
24時間の取引高:
1.05M
Relative Volume:
1.79
時価総額：
$777.42M
収益：
$116.88M
当期純損益:
$-25.09M
株価収益率:
-305.93
EPS:
-0.14
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
-2.53%
1か月 パフォーマンス:
-15.17%
6か月 パフォーマンス:
+119.87%
1年 パフォーマンス:
+160.05%
1日の値動き範囲:
$41.54
$42.91
1週間の範囲:
$41.54
$44.85
52週間の値動き範囲:
$15.50
$52.24
Rigel Pharmaceuticals Stock (RIGL) Company Profile
名前
Rigel Pharmaceuticals
セクター
電話
650-624-1100
住所
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
42.83 | 781.96M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-05 | アップグレード | Jefferies | Hold → Buy |
| 2023-04-03 | 再開されました | Piper Sandler | Neutral |
| 2022-06-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-06-08 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 開始されました | B. Riley Securities | Neutral |
| 2020-11-09 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 再開されました | JP Morgan | Overweight |
| 2019-03-01 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 開始されました | Citigroup | Buy |
| 2018-05-02 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 再開されました | Piper Jaffray | Overweight |
| 2017-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 再開されました | H.C. Wainwright | Buy |
| 2017-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-31 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-30 | 繰り返されました | Piper Jaffray | Overweight |
| 2016-07-13 | 開始されました | H.C. Wainwright | Buy |
| 2016-06-13 | 開始されました | Piper Jaffray | Overweight |
| 2016-04-22 | アップグレード | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 繰り返されました | Stifel | Buy |
| 2012-11-29 | 開始されました | UBS | Neutral |
| 2012-11-06 | 繰り返されました | Oppenheimer | Outperform |
| 2012-03-26 | 開始されました | Canaccord Genuity | Hold |
| 2010-12-10 | ダウングレード | MP Advisors | Outperform → Market Perform |
すべてを表示
Rigel Pharmaceuticals (RIGL) 最新ニュース
Range Financial Group LLC Makes New Investment in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case - Yahoo Finance
Inspire Investing LLC Makes New $859,000 Investment in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Momentum Shift: Will Rigel Pharmaceuticals Inc RI2 stock beat Nasdaq index returnsInsider Selling & Free Growth Oriented Trading Recommendations - moha.gov.vn
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 23% Below Their Intrinsic Value Estimate - 富途牛牛
Assenagon Asset Management S.A. Decreases Holdings in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
(RIGL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded to Buy at Wall Street Zen - MarketBeat
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - MSN
Can Rigel Pharmaceuticals Inc. stock deliver sustainable ROEJuly 2025 Snapshot & Weekly High Return Opportunities - Улправда
Will Rigel Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Consistent Growth Stock Picks - DonanımHaber
How Rigel Pharmaceuticals Inc. stock compares to market leadersJuly 2025 Breakouts & High Accuracy Trade Alerts - DonanımHaber
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Is Rigel Pharmaceuticals Inc. stock near bottom after declineQuarterly Profit Review & Verified Short-Term Plans - Улправда
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891 - MSN
Rigel Pharmaceuticals Earnings Notes - Trefis
Rigel Pharmaceuticals reports promising Phase 1b study results - MSN
Behavioral Patterns of RIGL and Institutional Flows - news.stocktradersdaily.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Rigel Pharma downgraded by Piper Sandler with a new price target - Quantisnow
Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m - simplywall.st
Rigel Pharmaceuticals, Inc. $RIGL Shares Bought by Globeflex Capital L P - MarketBeat
Armistice Capital LLC Acquires 84,000 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Top-Rated Stocks: Rigel Pharmaceuticals Sees Composite Rating Climb To 96 - MSN
Rigel Pharmaceuticals Reports Promising Phase 1b Study Results - TipRanks
Rigel Pharmaceuticals Inc Presents Updated Data from Phase 1b Study on R289 - TradingView — Track All Markets
Rigel Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 13.7%Should You Sell? - MarketBeat
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Rigel Pharmaceuticals (RIGL) is a great momentum stock: Should you buy? - MSN
Rigel Pharmaceuticals (RIGL) Shares Promising Data from Phase 1b Study - GuruFocus
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition - Lelezard
How the Narrative Surrounding Rigel Pharmaceuticals Is Shifting After Upgraded Targets and Guidance - Yahoo Finance
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - sharewise.com
Why Rigel Pharmaceuticals Inc. (RI2) stock could break out in 2025July 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Is Rigel Pharmaceuticals Inc. (RI2) stock supported by free cash flowTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidityWeekly Trade Review & Free High Accuracy Swing Entry Alerts - Newser
Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Year in Review & Verified Stock Trade Ideas - Newser
Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueMarket Sentiment Report & AI Based Trade Execution Alerts - Newser
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - sharewise.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 6.1%Time to Sell? - MarketBeat
Will Rigel Pharmaceuticals Inc. (RI2) stock outperform small cap peers2025 Market Overview & Weekly High Potential Stock Alerts - Newser
(RIGL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Would You Still Hold Rigel Pharmaceuticals Stock If It Fell Another 30%? - Trefis
Is Rigel Pharmaceuticals Inc. (RI2) stock a top dividend aristocrat candidatePortfolio Performance Report & Long-Term Investment Growth Plans - Newser
Is Rigel Pharmaceuticals Inc. (RI2) stock a buy before new product rolloutWeekly Market Summary & Stock Market Timing Techniques - Newser
Rigel Pharmaceuticals (RIGL) Stock Analysis Report | Financials & Insights - Benzinga
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleTake Profit & Long-Term Capital Growth Strategies - Newser
Is Rigel Pharmaceuticals Inc. stock a buy for dividend growthMarket Performance Summary & Verified Technical Signals - Newser
Rigel Pharmaceuticals (RIGL) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
0.08%
大文字化:
|
ボリューム (24 時間):